Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study.
Ram Chandra BajpaiRichard PartingtonSara MullerHarry ForresterChristian D MallenLorna ClarsonNishita PadmanabhanRebecca WhittleEdward RoddyPublished in: Rheumatology (Oxford, England) (2024)
People were given colchicine prophylaxis despite commonly having preexisting prescriptions for medications with potential to interact with colchicine. Adverse events were more common in people who had more comorbidities and certain potentially interacting medications. Our findings will provide much-needed information about prognostic factors for colchicine-related adverse events that can inform treatment decisions about prophylaxis when initiating allopurinol.